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*Proteus mirabilis* is one of the leading agents of urinary tract infections and can cause a number of different health care-associated infections, including mainly respiratory tract and skin infections, but also bacteremia ([@B1]). Due to a decreased susceptibility to imipenem and an intrinsic resistance to polymyxins and tetracyclines (including tigecycline), the acquisition of β-lactam resistance traits by *P. mirabilis* might seriously limit treatment options. KPC-type carbapenemases have become the most prevalent acquired carbapenemases in *Klebsiella pneumoniae* in several areas worldwide ([@B2]) and have been sporadically detected also in other *Enterobacteriaceae* and in Gram-negative nonfermenters ([@B3][@B4][@B6]). The acquisition of *bla*~KPC~ by *P. mirabilis* represents a rare event, and only a few descriptions have been reported to date ([@B7][@B8][@B9]). In this report, we announce the first complete genome sequence of a *P. mirabilis* strain carrying the *bla*~KPC-2~ gene.

*P. mirabilis* AOUC-001 was isolated in 2013 from the blood culture from an inpatient admitted to the Santa Maria Annunziata Hospital (Florence, Italy). A molecular test performed directly on positive blood culture, using the FilmArray platform (Biofire Diagnostics, UT), detected the presence of the *bla*~KPC~ gene.

Bacterial DNA was subjected to whole-genome sequencing using the MiSeq (Illumina, Inc., CA) and the PacBio RS II (Pacific Biosciences, CA, USA) platforms, which generated 4,643,660 and 1,841,288 reads, respectively**.** Short and long raw reads were processed with the PBcR hybrid assembly pipeline ([@B10]), producing 8 scaffolds (largest scaffold, 1.96 Mb; *N*~50~, 1.52 Mb; *L*~50~, 2; average G+C content, 39.42%). Genome finishing was achieved by manual inspection of the draft assembly, exploiting PacBio long reads for resolution of large repeats, and using short reads to close small gaps ([@B11]). The final *de novo* assembly generated a single molecule of 4,272,433 bp, with a raw coverage of 260×, representing the complete chromosome of AOUC-001.

A total of 3,853 coding sequences, 83 tRNAs, 22 rRNAs, and 1 type-IE clustered regularly interspaced short palindromic repeat (CRISPR)-associated (Cas) system were identified by the NCBI Prokaryotic Genome Annotation Pipeline (<http://www.ncbi.nlm.nih.gov/genome/annotation_prok>).

Screening for known virulence determinants ([@B12]) revealed the presence of genes associated with adhesion (mannose-resistant/*Proteus*-like fimbria \[MR/P\], *P. mirabilis* fimbria \[PMF\], and ambient-temperature fimbria \[ATF\] operons), motility (*flgE*, *fliFL*, *cheW*, and *flaD*), iron chelation (*hmurR2*, *znuC*, and *nrp* operon), and production of toxic compounds (*pta*, *hpmA*, and *zapA*).

The antimicrobial resistome of AOUC-001, investigated using ResFinder ([@B13]), included acquired determinants conferring resistance to aminoglycosides (*aadA1*, *aacA4*, *armA*, and *aph(3′)-Ic*), chloramphenicol (*cat* and *catA1*), trimethoprim (*dfrA1*), and sulfonamides (*sul1*). Additionally, four different β-lactamase genes (*bla*~CMY-16~, *bla*~TEM-1,~ *bla*~OXA-9~, and *bla*~KPC-2~) were detected. Interestingly, the *bla*~KPC-2~ gene was present in two copies.

Further analysis revealed that the two *bla*~KPC-2~ copies were embedded in two distinct Tn*4401a* transposons ([@B14]), arranged in a tail-to-tail configuration within the chromosome of AOUC-001. The flanking sequences of these transposons resembled the overall architecture of pKPN101-IT (accession no. JX283456), a KPC-encoding plasmid taken from a *K. pneumoniae* clinical isolate described in Italy in 2012 ([@B15]). Overall, this arrangement suggested a possible integration of a pKPN101-IT-like plasmid within the chromosome of AOUC-001, an event that might have been favored by the endemic presence of KPC-producing *K. pneumoniae* strains sharing the same setting ([@B16]).
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The complete genome of *P. mirabilis* AOUC-001 has been deposited at NCBI under the GenBank accession no. [CP015347](http://www.ncbi.nlm.nih.gov/nuccore/CP015347).
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